Innovative Technologies for Engineering Small Blood Vessels

The summary for the Innovative Technologies for Engineering Small Blood Vessels grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Technologies for Engineering Small Blood Vessels: The goal of this initiative is to apply recent advances in biomaterials, tissue engineering, and nanotechnology towards the development of small diameter (less than 5.0 mm inner diameter) functional blood vessels for clinical evaluation. The NHLBI invites applications from investigators interested in developing clinical products for vessel replacement therapy due to cardiovascular disease. This initiative will complement existing programs to apply innovative technologies, tissue engineering and nanofabrication methods, models, and novel biomaterials that overcome barriers toward the development of functional blood vessel substitutes.
Federal Grant Title: Innovative Technologies for Engineering Small Blood Vessels
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-05-013
Type of Funding: Grant
CFDA Numbers: 93.83793.839
CFDA Descriptions: Heart and Vascular Diseases Research 93.839 Blood Diseases and Resources Research
Current Application Deadline: No deadline provided
Original Application Deadline: May 17, 2005
Posted Date: Mar 04, 2005
Creation Date: Mar 04, 2005
Archive Date: Jun 16, 2005
Total Program Funding: $15,000,000
Maximum Federal Grant Award: $250,000
Minimum Federal Grant Award:
Expected Number of Awards: 3
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are not eligible to apply. Applications may be submitted by individual institutions or by consortia of institutions that have pooled their resources to be responsive to the terms of this RFA. It is anticipated that institutions with well-developed and innovative programs in vascular replacement therapy will apply to this announcement. Foreign institutions are not eligible to apply as the primary institution, but may enter into a subcontract with a domestic institution as the primary applicant.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
More Grants from the National Institutes of Health
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed)
Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical T...
Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical...
Limited Competition: NIDCD National Temporal Bone, Hearing and Balance Pathology Resource ... is not endorsed by, or affiliated with, any government agency. Copyright ©2018